The Journal of Immunology, Vol 146, Issue 3 819-825, Copyright © 1991 by American Association of Immunologists

ARTICLES

Growth regulation of a human mature B cell line, B104, by anti-IgM and anti-IgD antibodies

KM Kim, T Yoshimura, H Watanabe, T Ishigami, M Nambu, D Hata, Y Higaki, M Sasaki, T Tsutsui and M Mayumi
Department of Pediatrics, Faculty of Medicine, Kyoto University, Japan.

An EBNA- human B lymphoma cell line, B104, was established. B104 cells express IgD as well as IgM on their surface, which is thought to be a basic characteristic of mature B cells. The growth of B104 cells was inhibited by treatment with a panel of anti-IgM antibodies. Cell cycle analyses revealed that the transition of B104 cells from the G2/M to the G0/G1 phase of the cell cycle was markedly inhibited by treatment with anti-IgM antibodies. Progression of B104 cells to the M phase of the cell cycle was found to be suppressed in the presence of anti-IgM antibodies. In contrast, both the entrance of G0/G1 phase cells into the S phase and the progression of S phase cells to the G2/M phase of the cell cycle did not seem to be inhibited significantly by treatment with anti-IgM antibodies. These results indicate that the mechanism of the inhibition of growth of B104 cells by anti-IgM antibodies is blockage of the transition from the G2 to the M phase of the cell cycle. In contrast to anti-IgM antibodies, anti-IgD antibodies could not cause growth inhibition of B104 cells at all. B cell growth factors such as IL-4 and IL-6 had no effect on the inhibition of growth of B104 cells by anti-IgM antibody. IFN-alpha and -beta, which have no B cell growth factor activity, did increase the number of cells that survived the treatment with anti-IgM antibodies. B104 is an excellent experimental model for the study of the mechanism of signal transduction through sIg as well as the functional difference between sIgM and sIgD.

This article has been cited by other articles:

				E. Merck, C. Gaillard, D. M. Gorman, F. Montero-Julian, I. Durand, S. M. Zurawski, C. Menetrier-Caux, G. Carra, S. Lebecque, G. Trinchieri, et al. OSCAR is an FcR{gamma}-associated receptor that is expressed by myeloid cells and is involved in antigen presentation and activation of human dendritic cells Blood, September 1, 2004; 104(5): 1386 - 1395. [Abstract] [Full Text] [PDF]

				A. Jiang and E. A. Clark Involvement of Bik, a Proapoptotic Member of the Bcl-2 Family, in Surface IgM-Mediated B Cell Apoptosis J. Immunol., May 15, 2001; 166(10): 6025 - 6033. [Abstract] [Full Text] [PDF]

				R. Marches, E. S. Vitetta, and J. W. Uhr A role for intracellular pH in membrane IgM-mediated cell death of human B lymphomas PNAS, February 22, 2001; (2001) 61028998. [Abstract] [Full Text]

				S. Zupo, R. Massara, M. Dono, E. Rossi, F. Malavasi, M. E. Cosulich, and M. Ferrarini Apoptosis or plasma cell differentiation of CD38-positive B-chronic lymphocytic leukemia cells induced by cross-linking of surface IgM or IgD Blood, February 15, 2000; 95(4): 1199 - 1206. [Abstract] [Full Text] [PDF]

				W. Chen, H.-G. Wang, S. M. Srinivasula, E. S. Alnemri, and N. R. Cooper B Cell Apoptosis Triggered by Antigen Receptor Ligation Proceeds Via a Novel Caspase-Dependent Pathway J. Immunol., September 1, 1999; 163(5): 2483 - 2491. [Abstract] [Full Text] [PDF]

				J. D. Graves, K. E. Draves, A. Craxton, J. Saklatvala, E. G. Krebs, and E. A. Clark Involvement of stress-activated protein kinase and p38 mitogen-activated protein kinase in mIgM-induced apoptosis of human B lymphocytes PNAS, November 26, 1996; 93(24): 13814 - 13818. [Abstract] [Full Text] [PDF]

				R. Marches, E. S. Vitetta, and J. W. Uhr A role for intracellular pH in membrane IgM-mediated cell death of human B lymphomas PNAS, March 13, 2001; 98(6): 3434 - 3439. [Abstract] [Full Text] [PDF]